Darzalex Iv 57894-0505

Generic: Daratumumab

Product NDC

57894-0505

Manufacturer: Janssen Biotech, Inc.
Dosage Form: Injection, Solution, Concentrate
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: October 15, 2021
Listing Expires: December 31, 2027
Application: BLA761036

Need to source Darzalex Iv? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Daratumumab	100 mg/5mL

Drug Class

CD38-directed Cytolytic Antibody [EPC]AntibodiesMonoclonal [CS]

Packaging Options(2)

57894-0505-05

1 VIAL, SINGLE-DOSE in 1 BOX (57894-505-05) / 5 mL in 1 VIAL, SINGLE-DOSE

View →

57894-0505-20

1 VIAL, SINGLE-DOSE in 1 BOX (57894-505-20) / 20 mL in 1 VIAL, SINGLE-DOSE

View →